Controversies in the radiotherapeutic management of poor prognosis locally advanced prostate cancer

A M Henry; P Price; J P Logue; R A Cowan; J H Shanks; D P Dearnaley; V S Khoo

doi:10.1016/j.clon.2003.10.012

Controversies in the radiotherapeutic management of poor prognosis locally advanced prostate cancer

Clin Oncol (R Coll Radiol). 2004 Apr;16(2):87-94. doi: 10.1016/j.clon.2003.10.012.

Authors

A M Henry¹, P Price, J P Logue, R A Cowan, J H Shanks, D P Dearnaley, V S Khoo

Affiliation

¹ Academic Department of Radiation Oncology, Christie Hospital NHS Trust, Manchester, UK.

PMID: 15074729
DOI: 10.1016/j.clon.2003.10.012

Abstract

The Grand Round was held at the Christie Hospital, Manchester, U.K., on 30 November 2002. It followed a presentation by Dr David Dearnaley from the Royal Marsden Hospital in Sutton on 'Novel approaches and trials in prostate cancer'. Controversies in the management of locally advanced prostate cancer were illustrated by a case presentation and followed by a discussion on the evaluation of disease extent, and the roles of radiotherapy and hormone ablation.

Publication types

Clinical Conference
Research Support, Non-U.S. Gov't

MeSH terms

Androgen Antagonists / therapeutic use*
Chemotherapy, Adjuvant
Humans
Male
Middle Aged
Neoplasm Staging
Prognosis
Prostate-Specific Antigen / analysis
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / pathology*
Prostatic Neoplasms / radiotherapy*

Substances

Androgen Antagonists
Prostate-Specific Antigen